期刊文献+

C反应蛋白对多发性骨髓瘤细胞株U266生长影响的研究

Influence of C-reactive protein on proliferation of U266 cells
原文传递
导出
摘要 目的探讨C反应蛋白(CRP)对多发性骨髓瘤细胞株U266细胞株生长的影响及其机制。方法将CRP(浓度为0、5、10、20mg/L)与U266细胞株作用24h后,血液分析仪检测细胞增生情况;采用反转录-聚合酶链反应(RT—PCR)方法检测凋亡相关基因Survivin和HSP-90α的表达。结果培养24h后,U266细胞增生率明显提高(P〈0.05),且与CRP浓度成正比,CRP浓度为20mg/L时,细胞增生最明显;U266细胞表达Survivin、HSP-90α,其表达量随CRP浓度的增高而增高(P〈0.05)。结论CRP可促进U266细胞株增生,并通过调节凋亡抑制蛋白Survivin及HSP-90α表达的增高发挥其诱导U266细胞增生的作用。 Objective In the present study, we examined the expression changes of Survivin/HSP90α, in C-reactive protein(CRP) treated human muhiple meyloma (MM) cell lies. Methods The human MM cell lines were cultured for 3 days and incubated with human CRP(0.5, 10, 20 mg/L for 24 hours) and analyzed by blood analyser for proliferation ratio. The effects of CRP in MM cell lines in various concentrations on survivin/HSP-90α mRNA expression were examined by RT-PCR. Results Proliferation ratio of U266 cell line was signitieantly increased, and the expression of survivin/HSP-90α were upregulated (gene promoting cell survival) at mRNA levels in proportion to increased CRP concentrations. Conclusion These results demonstrated that proliferation ratio, survivin and HSP-90α could be regulated by CRP in MM cells.
出处 《白血病.淋巴瘤》 CAS 2009年第9期532-534,共3页 Journal of Leukemia & Lymphoma
基金 山西省留学人员科研资助项目(20081099)
关键词 C反应蛋白质 基因 SURVIVIN 热休克蛋白-90α C-Reactive protein Gene, Survivin HSP-90α
  • 相关文献

参考文献9

  • 1邱录贵.多发性骨髓瘤的发病与国人特点[J].中国实用内科杂志:临床前沿版,2006,26(6):886-888. 被引量:52
  • 2王晓冬,张晋琳,万纯黔.多发性骨髓瘤患者C反应蛋白水平与病程及预后的关系[J].四川医学,2000,21(8):718-719. 被引量:5
  • 3Yang J, Wezeman M, Zhang X, et al. Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor eells from apoptosis. Cancer Cell, 2007, 12: 252-265.
  • 4胡影,陈世伦,黄晓楠,安娜.环氧合酶-2在多发性骨髓瘤中的表达及其临床意义[J].白血病.淋巴瘤,2008,17(5):337-339. 被引量:5
  • 5Ambrosni G, Adida C, Altieni DC. A novel anti-apoptnsis gone, survivin expressed in cancer and lymphoma. Nat Med, 1997, 3: 917-921.
  • 6Pandey P, Saleh A, Nakazawa A, et al. Negative regulation of cytochrome c-mediated oligomerization Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J, 2000, 19: 4310-4322.
  • 7Nimmanapalli R, O Bryan E, Bhalla K. Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamyein lowers Bcr-Ahl levels and induces apoptosis and differentiation of Bcr-Ahl-positive human leukemic blasts. Cancer Res, 2001,61: 1799-1804.
  • 8Hostein I, Robertson D, Distefano F, et al. Inhibition of signal transduction by 17-allylamino- 17-demethoxygehtanamycin results in cytostasis and apnptosis. Cancer Res, 2001, 61: 4003-4009.
  • 9Andrulis M, Chatterjee M, Jain S, et al. Heat shock protein 90 alpha and beta are overexpressed in multiple myeloma cells and critically contribute to survival. Verh Dtseh Ges Pathol, 2007, 91: 330-337.

二级参考文献16

  • 1麦玉洁,邱录贵,李睿,靳风艳,白洁,万长春,王建祥,季林祥,肖志坚,钱林生.432例多发性骨髓瘤临床分析[J].白血病.淋巴瘤,2004,13(4):198-201. 被引量:27
  • 2张之南.血液病诊断及疗效标准(第2版)[M].北京:科学出版社,1997.211-213.
  • 3Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes[J]. J Clin Invest, 2001, 107(12): 1491-1495.
  • 4Cetin M, Buyukberter S, Demir M, et al. Overexpression of cyclooxygenase-2 in multiple myeloma:association with reduced survival[J]. Am J Hematol, 2005, 80(3): 169-173.
  • 5Yoshimoto T, Takahashi Y, Kinoshita T, et al. Growth stimulation and epiderm al growth factor receptor induction in cyclooxygenase overexpressing human colon carcinoma cells[J]. Adv Exp Med Biol, 2002, 507(5): 403-407.
  • 6Ladetto M, Vallet S, Trojan A, et al. Cyclooxygenase-2(COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome[J]. Blood, 2005, 105(12): 4784-4791.
  • 7Trojan A, Tinguely M, Vallet S, et al. Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma [J]. Swiss Med Wkly, 2006, 136(25): 400-403.
  • 8Zhang M, Abe Y, Matsushima T, et al. Selective cyelooxygenase 2 inhibitor NS-398 induces apoptosis in myeloma cells via a bcl-2 independent pathway[J]. Leukemia and Lymphoma, 2005, 46(3): 425-433.
  • 9Pai R, Soreghan B, Szabo IL, el al. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy[J]. Nat Med, 2002, 8(3): 289-293.
  • 10Sandier RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent eoloreetal adenomas in patients with previous eoloreetal cancer[J]. N Eng J Med, 2003, 348(10): 883-890.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部